Investors

Presentations & Videos 2021

2020

For investor-related information please contact Ronn Bechler at Market Eye
Ph: +61 3 9591 8901 E: ronn.bechler@marketeye.com.au

Zelira Therapeutics’ commercialisation program

Zelira to launch a suite of new cannabinoid-based products in FY22 – Proactive

Channel 9 News Perth

Zelira Therapeutics and Curtin University partner on research of proprietary technology that demonstrates significant uptake of CBD into the brain

Presentation at Cantor Fitzgerald International Cannabis Forum

Zelira Therapeutics Investor Slide Deck

Zelira Chairman, Osagie Imasogie and CEO Oludare Odumosu

Zelira Chairman Presentation at Cantor Fitzgerald International Cannabis Forum

Zelira Therapeutics and Levin Health

Talking about the upcoming chronic pain clinical trial

Zelira Therapeutics well positioned

Zelira Therapeutics are well positioned for ‘multiple product launches in 2021’

Proactive – Zelira Therapeutics sees ‘multiple shots on goal’ with a number of revenue streams

Start typing and press Enter to search

Shopping Cart